176 related articles for article (PubMed ID: 9890489)
1. Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.
Lin K; Nguyen BD; Ettinger DS; Chin BB
Clin Nucl Med; 1999 Jan; 24(1):24-8. PubMed ID: 9890489
[TBL] [Abstract][Full Text] [Related]
2. [Thymoma and somatostatin analogs. Biology, diagnostic and clinical practice].
Palmieri G; Montella L; Lastoria S
Minerva Endocrinol; 2001 Sep; 26(3):193-5. PubMed ID: 11753243
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.
Marienhagen J; Schalke B; Aebert H; Held P; Eilles C; Bogdahn U
Pathol Res Pract; 1999; 195(8):575-81. PubMed ID: 10483589
[TBL] [Abstract][Full Text] [Related]
5. Detection of malignant thymoma in primary tumor and metastatic lesions using 99mTc-tetrofosmin scintigraphy.
Hashimoto T; Takahashi K; Goto M; Endo H; Kono T; Nishiyama H; Iimura F; Kuwashima S; Sawada H; Saiki N; Yamato M; Fujioka M
Radiat Med; 2001; 19(3):169-72. PubMed ID: 11467386
[TBL] [Abstract][Full Text] [Related]
6. Current role of 111In-DTPA-octreotide scintigraphy in diagnosis of thymic masses.
Guidoccio F; Grosso M; Maccauro M; Orsini F; Perri M; Boni G; Banti E; Grassetto G; Rubello D; Mariani G; Volterrani D
Tumori; 2011; 97(2):191-5. PubMed ID: 21617714
[TBL] [Abstract][Full Text] [Related]
7. Role of somatostatin analogue-based therapy in unresponsive malignant thymomas.
Palmieri G; Lastoria S; Montella L; Martignetti A; Lombardi G; Salvatore M; Bianco AR
Ann Med; 1999 Oct; 31 Suppl 2():80-5. PubMed ID: 10574161
[TBL] [Abstract][Full Text] [Related]
8. [Somatostatin analogs in the clinical management of pituitary neoplasms].
Colao A; Dorato M; Pulcrano M; Rossi FW; Auriemma RS; Lombardi G; Lastoria S
Minerva Endocrinol; 2001 Sep; 26(3):181-91. PubMed ID: 11753242
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.
Breeman WA; de Jong M; Kwekkeboom DJ; Valkema R; Bakker WH; Kooij PP; Visser TJ; Krenning EP
Eur J Nucl Med; 2001 Sep; 28(9):1421-9. PubMed ID: 11585303
[TBL] [Abstract][Full Text] [Related]
10. [Isotopic scan with somatostatin receptors in a case of recurrent carcinoid tumor. Relevance of tomographic detection].
Bernà Roqueta L; Martín Marimón JC; Martín Martínez J
Rev Esp Med Nucl; 2002 Apr; 21(2):123-4. PubMed ID: 11879622
[No Abstract] [Full Text] [Related]
11. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
[TBL] [Abstract][Full Text] [Related]
12. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
13. Functional imaging of thymic disorders.
Lastoria S; Palmieri G; Muto P; Lombardi G
Ann Med; 1999 Oct; 31 Suppl 2():63-9. PubMed ID: 10574158
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease.
Colao A; Pivonello R; Lastoria S; Faggiano A; Ferone D; Lombardi G; Fenzi G
Eur J Endocrinol; 2000 Oct; 143 Suppl 1():S35-42. PubMed ID: 11068938
[No Abstract] [Full Text] [Related]
15. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide.
Schillaci O; Annibale B; Scopinaro F; delle Fave G; Colella AC
J Nucl Med; 1997 Jun; 38(6):886-7. PubMed ID: 9189135
[TBL] [Abstract][Full Text] [Related]
16. [Imaging of metastases from thyroid carcinomas using 111In-pentetreotide scintigraphy].
Görges R; Eissner D; Kahaly G; Voges E; Kersjes W; Bockisch A
Nuklearmedizin; 1995 Aug; 34(4):165-9. PubMed ID: 7675648
[TBL] [Abstract][Full Text] [Related]
17. Transdiaphragmatic extension of invasive thymoma.
Scatarige JC; Fishman EK; Zerhouni EA; Siegelman SS
AJR Am J Roentgenol; 1985 Jan; 144(1):31-5. PubMed ID: 3871144
[TBL] [Abstract][Full Text] [Related]
18. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor imaging: predictive and prognostic considerations.
Anthony LB; Martin W; Delbeke D; Sandler M
Digestion; 1996; 57 Suppl 1():50-3. PubMed ID: 8813470
[TBL] [Abstract][Full Text] [Related]
20. Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.
Balon HR; Goldsmith SJ; Siegel BA; Silberstein EB; Krenning EP; Lang O; Donohoe KJ;
J Nucl Med; 2001 Jul; 42(7):1134-8. PubMed ID: 11438641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
